AbCellera Biologics Inc.

NASDAQ: ABCL · Real-Time Price · USD
4.58
0.08 (1.78%)
At close: Aug 15, 2025, 3:59 PM
4.61
0.66%
After-hours: Aug 15, 2025, 07:54 PM EDT

AbCellera Biologics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-5.3 -11.28 18.22 25.70
PEG Ratio
-0.68 0.06 n/a 0.94
PS Ratio
29.91 43.42 5.95 10.51
PB Ratio
0.82 1.43 2.34 3.84
P/FCF Ratio
-4.61 -13.6 14.11 21.19
P/OCF Ratio
-7.94 -37.63 10.41 16.12
OCF/S Ratio
-3.76 -1.15 0.57 0.65
Debt / Equity Ratio
0.06 0.07 0.07 0.04
Quick Ratio
9.81 7.32 8.65 7.69
Current Ratio
9.81 7.33 8.67 7.70
Asset Turnover
0.02 0.03 0.32 0.28
Interest Coverage
n/a n/a 53.53 39.12
Return on Equity
-0.15 -0.13 0.13 0.15
Return on Assets
-0.12 -0.1 0.10 0.12
Return on Invested Capital
-0.2 -0.15 0.10 0.12
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-2.36 0.19 0.86 0.88
Net Profit Margin
-5.65 -3.85 0.33 0.41
Pretax Profit Margin
-6.95 -4.58 0.49 0.58
Operating Profit Margin
-10.92 -6.24 0.45 0.54
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-7.08 -5.05 0.56 0.64